Neurognostics fMRI to be used in Huntingtons disease study

Neurognostics, a Milwaukee-based provider of integrated functional MR imaging (fMRI) services, has signed an agreement to install its fMRI system at The Cleveland Clinic and The University of Iowa for a multi-center Huntington's disease study.

Huntington's disease is an inherited central nervous system disorder that results in abnormal body movements and a lack of coordination, and can progressively affect mood, memory, and concentration.

In addition to using its Functional Acquisition Device for the researchers to acquire subject data, Neurognostics has implemented three specific stimulation paradigms, according to the company.

Around the web

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.